Your browser doesn't support javascript.
loading
Prophylactic versus Preemptive modified donor lymphocyte infusion for high-risk acute leukemia after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study.
Yang, Luxin; Lai, Xiaoyu; Yang, Ting; Lu, Ying; Liu, Lizhen; Shi, Jimin; Zhao, Yanmin; Wu, Yibo; Chen, Yi; Yu, Jian; Xiao, Haowen; Ouyang, Guifang; Ren, Jinhua; Cao, Junjie; Hu, Yongxian; Tan, Yamin; Ye, Yishan; Cai, Zhen; Xu, Weiqun; Huang, He; Luo, Yi.
Afiliación
  • Yang L; Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Lai X; Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, 311121, China.
  • Yang T; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Lu Y; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Liu L; Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Shi J; Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, 311121, China.
  • Zhao Y; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Wu Y; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Chen Y; Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fuzhou, China.
  • Yu J; Department of Hematology, The First Afliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
  • Xiao H; The affiliated people's hospital of Ningbo University, Ningbo, China.
  • Ouyang G; Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Ren J; Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, 311121, China.
  • Cao J; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Hu Y; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Tan Y; Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Ye Y; Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, 311121, China.
  • Cai Z; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Xu W; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Huang H; Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Luo Y; Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, 311121, China.
Bone Marrow Transplant ; 59(1): 85-92, 2024 01.
Article en En | MEDLINE | ID: mdl-37907756
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2024 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2024 Tipo del documento: Article País de afiliación: China